Leaflet MIRVASO 3mg / g gel

Product code:
W60936002
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
cutaneous
Substance:
brimonidine (glaucoma agent)
ATC
D11AX21 — Dermatologicals | Other dermatological preparations | Other dermatological preparations | Other dermatologicals
Brimonidine is a medication used to treat open-angle glaucoma and ocular hypertension. It belongs to the class of alpha-2 adrenergic receptor agonists and works by reducing the production of aqueous humor and increasing its outflow, thereby lowering intraocular pressure.

It is available as eye drops and is typically administered two to three times a day, as directed by a doctor. Brimonidine is effective in preventing optic nerve damage caused by elevated intraocular pressure.

Side effects may include a burning or stinging sensation in the eyes, dry eyes, redness, headache, drowsiness, or dizziness. It is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and should be used with caution in those with severe cardiovascular conditions.

General data about MIRVASO 3mg / g

Substance:
brimonidine
Date of latest medicines list:
01-10-2020
Product code:
W60936002
Concentration:
3mg / g
Pharmaceutical form:
gel
Quantity:
1
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Pharmaceutical forms available for brimonidine

Concentrations available for brimonidine

  • 0.25mg/ml
  • 2mg/ml
  • 3mg/g

Combinations with other substances